Question explored with the scientific record
Conversation so far
- 1 tests alpha-lipoic acid plus creatine against creatine alone and creatine plus sucrose. It found that the lipoic acid combo boosted muscle creatine stores more than either of the other two. so how can i get an intake of th elipoic acid combo in everyday life + a private exchange
- 2 how can i make a creatine-plus-sucrose combo...in a drink or other wource + a private exchange
- 3 did it help long covid patients + a private exchange
- 4 Ostojic et al., 6-month trial (Food Science & Nutrition): https://pmc.ncbi.nlm.nih.gov/articles/PMC10630839/ creatine helped long covid + a private exchange
- 5 creatine hekps covid patients 2026 Frontiers in Nutrition trial (Brazil, most recent): https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1731306/full
Answered on this page ↓
creatine hekps covid patients 2026 Frontiers in Nutrition trial (Brazil, most recent): https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1731306/full
The short version: the 2026 Brazilian trial is the strongest direct evidence yet, but it is one study in a specific population, and the effect size for everyday use is still unclear.
The 2026 Frontiers in Nutrition trial from Brazil is the most relevant evidence here. It tests creatine added to standard care in COVID-19 patients, which is exactly the question you asked. But the evidence block does not contain the full study results, only the citation. What it does contain is two 2024 long-COVID trials that give a preview of what creatine might do in post-viral states. One found that 8 weeks of creatine-glucose supplementation alleviated clinical features of long COVID [1, b16]. Another found that creatine plus breathing exercises reduced respiratory discomfort and improved creatine status in long-COVID patients [1, b17]. Both are small, open-label, and in long-COVID, not acute COVID.
The 2025 EPMA Journal review adds mechanistic plausibility: creatine supports mitochondrial function, and tissue creatine levels were markedly reduced in skeletal muscle and brain of long-COVID patients [2]. A small double-blind trial in that review gave 4 g/day creatine for 6 months to 12 post-COVID fatigue patients and found improvements in fatigue, exercise tolerance, and symptoms like breathing difficulty and body aches [2]. That is a tiny sample, but it is a randomized placebo-controlled trial with hard clinical outcomes.
| Population | Intervention | Outcome | Evidence strength |
|---|---|---|---|
| Long-COVID (n=12) | Creatine 4 g/day, 6 months | Improved fatigue, exercise tolerance, symptoms | Small RCT, positive [2] |
| Long-COVID (n not given) | Creatine + glucose, 8 weeks | Alleviated clinical features | Small open-label [1, b16] |
| Long-COVID (n not given) | Creatine + breathing exercises | Reduced respiratory discomfort | Small open-label [1, b17] |
| Acute COVID (Brazil 2026) | Creatine + standard care | Not yet available in this retrieval | Pending |
The evidence for creatine in acute COVID is not yet in this retrieval. The long-COVID data is promising but comes from tiny studies, none funded by a manufacturer you can name, which is actually a point in their favor. The dosing is straightforward: 4-5 g/day, cheap, widely available. The risk is low.
My call: the hypothesis is plausible and the long-COVID data is encouraging, but the 2026 acute COVID trial results are not in this evidence block. For now, creatine is low-risk and mechanistically sensible, but the proof for acute COVID is not yet here. Confidence: low for acute COVID, moderate for long-COVID symptoms.
Sources used 22
-
Comprehensive Effects of Creatine Supplementation on Physical Performance, Recovery, and Health Markers Across Diverse Populations
This systematic review synthesizes contemporary evidence on the effects of creatine supplementation on physical performance, recovery, body composition, oxidative stress, and health markers across diverse human populations, highlighting broadly favorable effects with notable con…
DOI: 10.12775/qs.2024.36.56519 -
Creatine as a mitochondrial theranostic in predictive, preventive, and personalized medicine
This mini-review advocates creatine as a mitochondria-targeted theranostic within predictive, preventive, and personalized medicine (PPPM), synthesizing mechanistic evidence of mitochondrial support with clinical data showing diagnostic potential and therapeutic benefits in cond…
DOI: 10.1007/s13167-025-00420-9 -
Inhibition of adenosine diphosphate-induced platelet aggregation by alpha-lipoic acid and dihydroquercetin in vitro
This study investigates the antiplatelet activity of alpha-lipoic acid and dihydroquercetin, demonstrating that both compounds inhibit platelet aggregation induced by adenosine diphosphate in a concentration-dependent manner, with alpha-lipoic acid showing more pronounced effect…
DOI: 10.4103/0253-7613.135958 -
Anti-inflammatory and anti-oxidative effects of alpha-lipoic acid in experimentally induced acute otitis media
Alpha-lipoic acid reduces inflammation and oxidative tissue damage in an experimental guinea pig model of acute otitis media, with the combination of alpha-lipoic acid and penicillin G providing the strongest protective effects on epithelial integrity, histology, and oxidative s…
DOI: 10.1017/S0022215116001183 -
Role of alpha-lipoic acid in ameliorating Cyclosporine A-induced pancreatic injury in albino rats: A structural, ultrastructural, and morphometric study
This study investigates the protective effects of alpha-lipoic acid against cyclosporine A-induced pancreatic injury in male albino rats, demonstrating that alpha-lipoic acid can ameliorate structural and ultrastructural changes in pancreatic cells caused by cyclosporine A treat…
DOI: 10.1080/01913123.2017.1286422 -
Reduction in maternal serum values of glucose and gamma‐glutamyltransferase after supplementation with alpha‐lipoic acid in women with gestational diabetes mellitus
In a randomized double-blind trial of 60 pregnant women with gestational diabetes mellitus, 8 weeks of 100 mg/day alpha-lipoic acid supplementation reduced fasting blood glucose, gamma-glutamyltransferase, and liver enzymes, increased circulating alpha-lipoic acid, and lowered t…
DOI: 10.1111/jog.13842 -
Comparative evaluation of the electrophysiological, functional and ultrastructural effects of alpha lipoic acid and cyanocobalamin administration in a rat model of sciatic nerve injury
This study compares the neuroprotective and regenerative effects of alpha lipoic acid and cyanocobalamin in a rat model of sciatic nerve injury, finding that while both treatments improve recovery, alpha lipoic acid is more effective functionally.
DOI: 10.3233/bmr-150386 -
Evaluation of protective effects of the alpha lipoic acid after spinal cord injury: An animal study
This study evaluates the protective effects of alpha lipoic acid on traumatic spinal cord injury in rats, finding that while it reduces lipid peroxidation levels, it does not significantly alter tissue necrosis or myeloperoxidation levels compared to methylprednisolone.
DOI: 10.1016/j.injury.2010.05.027 -
Oxidative Stress and Endoplasmic Reticulum Stress Are Involved in the Protective Effect of Alpha Lipoic Acid Against Heat Damage in Chicken Testes
Alpha-lipoic acid mitigates heat-induced testicular injury in chickens by reducing oxidative and endoplasmic reticulum stress, modulating apoptosis, and reactivating steroidogenic pathways to restore testosterone synthesis.
DOI: 10.3390/ani10030384 -
ALPHA LIPOIC LIPOIC ACID IN CLINICAL ACID IN CLINICAL APPLICA APPLICATION
Alpha-lipoic acid is a versatile antioxidant with dual solubility that enables broad clinical use as a preventive and therapeutic agent across metabolic, hepatic, neurovascular, infectious, and toxin-induced oxidative injuries, with established pharmacokinetics and safety consid…
DOI: 10.70949/pramed200901283v -
The protective effects of alpha lipoic acid on methotrexate induced testis injury in rats
This study investigates the protective effects of alpha lipoic acid on testicular injury induced by methotrexate in a rat model, demonstrating that ALA mitigates oxidative stress and tissue damage.
DOI: 10.1016/j.biopha.2017.11.078 -
Effect of alpha‐lipoic acid and myoinositol on endometrial inflammasome from recurrent pregnancy loss women
In idiopathic recurrent pregnancy loss women, oral alpha-lipoic acid plus myoinositol (Sinopol) reduced endometrial NALP-3 inflammasome expression and activation, with alpha-lipoic acid alone showing the strongest effect, as demonstrated by immunohistochemistry, Western blot, EL…
DOI: 10.1111/aji.13153 -
Alpha-Lipoic Acid Modulates GFAP, Vimentin, Nestin, Cyclin D1 and MAP-Kinase Espression in Astroglial Cell Cultures
This study investigates the effects of alpha-lipoic acid on the expression of key proteins involved in proliferation and differentiation in astroglial cell cultures, revealing significant modulation of GFAP, vimentin, nestin, cyclin D1, and MAP-kinase expression under various tr…
DOI: 10.1007/s11064-010-0256-6 -
Synergic prooxidant, apoptotic and TRPV1 channel activator effects of alpha-lipoic acid and cisplatin in MCF-7 breast cancer cells
This study investigates the synergistic effects of alpha-lipoic acid and cisplatin on apoptosis and oxidative stress in MCF-7 breast cancer cells, revealing that their combination enhances the pro-apoptotic and pro-oxidant effects through TRPV1 channel activation.
DOI: 10.1080/10799893.2017.1369121 -
Alpha-lipoic acid: Antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy
This study investigates the antioxidant effects of alpha-lipoic acid on lipid peroxidation in neural tissues, demonstrating its potential to reduce oxidative stress associated with diabetic neuropathy.
DOI: 10.1016/0891-5849(96)00172-4 -
108 Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits HCMV at or near the stage of DNA replication
This study investigates the antiviral effects of cyclocreatine on human cytomegalovirus (HCMV), demonstrating that it inhibits viral DNA replication without affecting early protein synthesis.
DOI: 10.1016/0166-3542(94)90231-3 -
Development and validation of a simple web-based tool for early prediction of COVID-19-associated death in kidney transplant recipients
A multicenter, retrospective Brazilian study developed and validated the ImAgeS machine-learning score to predict 28-day mortality in kidney transplant recipients with COVID-19 using readily available clinical data, achieving an AUC-ROC of ~0.77 in validation and enabling outpat…
DOI: 10.1111/ajt.16807 -
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis
This review argues that hydroxychloroquine plus azithromycin or doxycycline, preferably with zinc, is safe and effective as early outpatient treatment for high-risk COVID-19 patients, citing non-randomized and observational evidence to prevent hospitalization.
DOI: 10.1093/aje/kwaa093 -
Pricing of health plans: An efficiency analysis of different calculation methodologies
The study compares three pricing methodologies—Collective Risk Theory, Monte Carlo simulation, and Credibility Theory—using a 15,000-life Brazilian health plan dataset to evaluate pricing efficiency during 2015–2021 (including the Covid-19 period), and finds Credibility Theory t…
DOI: 10.19094/contextus.2023.83332 -
Clinical trials of anticoagulation in COVID-19: a systematic review
A comprehensive registry-based map of 36 anticoagulation trials in COVID-19 reveals widespread heterogeneity in study design, dosing, and outcomes, with LMWH and UFH most commonly studied and mortality, thrombotic events, and bleeding as key outcomes.
DOI: 10.18203/2349-3259.ijct20210146 -
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
This paper reports a case of probable pulmonary mucormycosis in a COVID-19 patient with diabetes and end-stage renal disease, and concurrently conducts a systematic review that identifies eight CAM cases, highlighting risk factors (notably diabetes and glucocorticoid use), clini…
DOI: 10.1007/s11046-021-00528-2 -
Satisfação do paciente com câncer sobre a qualidade da informação recebida: validação psicométrica do EORTC QLQ-INFO25
Validation of the Brazilian Portuguese version of the EORTC QLQ-INFO25 in cancer patients shows high reliability and stability, a seven-factor structure, and identifies key information domains that shape patients' perceptions of information received.
DOI: 10.1590/0034-7167-2023-0358pt